Cardiovascular
EXTENSION, INC. to Launch Apple iPhone Application for Use in Clinical Workflows
November 8, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsFORT WAYNE, Ind., Nov. 8, 2010 /- EXTENSION, INC . announced today that in addition to its Cisco IP device integration, it will make available for general release to the healthcare community the EXTENSION for Apple iPhone application . EXTENSION's existing offerings use Cisco IP devices...
Harvard's headache cure: LSD?
November 7, 2010 8:34 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsMove over, Advil. Harvard Medical School researcher John Halpern says LSD, the hallucinogen at the heart of the 1960s drug counterculture, holds a better treatment for cluster headaches, and he's formed a company he hopes will bring to market a drug based on his research.
United American Healthcare Corporation Announces Senior Management Appointments and Relocation to Chicago
November 5, 2010 5:32 am | by Bio-Medicine.Org | News | CommentsDETROIT, Nov. 5, 2010 /- United American Healthcare Corporation (OTCQB: UAHC) today announced that its Board of Directors has approved key appointments to the Company's senior management team. UAHC management also announced that the Company will relocate its headquarters from...
Biogen ends collaboration with Cardiokine
November 4, 2010 12:35 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsBiogen Idec Inc. and its Philadelphia-based partner Cardiokine Inc. have ended a collaboration on lixivaptan, a drug candidate for hyponatremia, or low sodium levels in the blood.
ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China
November 4, 2010 12:34 pm | by Bio-Medicine.Org | News | CommentsRANCHO CORDOVA, Calif., Nov. 4, 2010 /- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today it has signed a distribution agreement covering China and Hong Kong for its products used to prepare cell...
Gentris Corporation Names New Chief Scientific Advisor
November 4, 2010 12:34 pm | by Bio-Medicine.Org | News | CommentsMORRISVILLE, N.C., Nov. 4, 2010 /- Gentris Corporation ( www.gentris.com ), a global leader in applied clinical pharmacogenomics, announced today that Howard McLeod, Pharm.D., from The University of North Carolina at Chapel Hill (UNC) has become the Company's first Chief Scientific...
FDA Reclassifies Certain Digital Mammography Devices
November 4, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md., Nov. 4, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that it is easing the pathway to market for mammography systems that produce computerized X-ray images of the entire breast. (Logo: ...
AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System
November 4, 2010 9:34 am | by Bio-Medicine.Org | News | CommentsCOLD SPRING HARBOR, N.Y., Nov. 4, 2010 /- AccuVein LLC, the developer of the first non-contact, handheld vein illumination system, announced today that it had been awarded the maximum grant amount from the Qualifying Therapeutic Discover Project (QTDP) program. This Federal grant...
Biogen Idec to Close San Diego Site
November 3, 2010 11:31 pm | by San Diego Business Journal | News | CommentsBiogen Idec Inc., one of the world's largest makers of multiple sclerosis drugs, said Nov. 3 that it was restructuring its operations by closing its San Diego site along with two other facilities in Massachusetts.
Georgia Tech Hosts Sickle Cell Disease Symposium
November 3, 2010 8:34 am | by Georgia Tech Institute of Technology | News | CommentsGeorgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder.
IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITASâ„¢
November 3, 2010 3:33 am | by Bio-Medicine.Org | News | CommentsWEBSTER, Texas, Nov. 3, 2010 /- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to market the SUPERA VERITAS...
Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in...
November 2, 2010 7:33 pm | by Bio-Medicine.Org | News | CommentsBASKING RIDGE, N.J., Nov. 2, 2010 /- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior Vice President and Chief Medical Officer, presented an...
Eli Lilly and Company to Open a Diabetes-Focused Research Center in China
November 2, 2010 12:33 am | by Bio-Medicine.Org | News | CommentsINDIANAPOLIS, Nov. 2, 2010 /- Eli Lilly and Company (NYSE: LLY ) announced today plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic proportions. The center, to open in Shanghai in the second half of 2011, will focus on...
7,000 Bracelets For Hopeâ„¢ - A Rare Disease Awareness Campaign
November 1, 2010 3:33 am | by Bio-Medicine.Org | News | CommentsDANA POINT, Calif., Nov. 1, 2010 /PRNewswire-USNewswire/ -- The Global Genes Project ( www.globalgenesproject.org ), a non-profit advocacy organization that aims to raise awareness about the prevalence of rare diseases worldwide, today launched the 7,000 Bracelets for Hope™...
Lilly CEO: 'Are We Getting Our Money's Worth from Medical Innovation?'
October 29, 2010 9:33 am | by Bio-Medicine.Org | News | CommentsDALLAS, Oct. 29 /- In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company (NYSE: LLY ), said that the value of medical innovation – particularly innovative medicines – far outstrips its cost....
VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
October 29, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Oct. 29 /- See video from Roche Pharmaceuticals at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=23a45dd7-b... Roche announced on October 29 that the European Commission has...
FDA Approves Additional Medical Indication for Sprycel
October 28, 2010 11:33 am | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md., Oct. 28 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase...
Aethlon Medical Names Rod Kenley President
October 28, 2010 8:32 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Oct. 28 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has named Rod Kenley to be President of Aethlon Medical. Aethlon Chairman and CEO, Jim...
Gen-Probe to Webcast Two Upcoming Investor Presentations
October 27, 2010 6:32 pm | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Oct. 27 /- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at the Oppenheimer 21st Annual Healthcare Conference in New York on November 2, 2010 at 11:25 a.m. Eastern time, and at the Lazard Capital Markets 7th Annual Healthcare Conference in...
Advancements in Technology Benefit Cardiology Patients at Palos Community Hospital
October 27, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsPALOS HEIGHTS, Ill., Oct. 27 /PRNewswire-USNewswire/ -- Interventional cardiologists affiliated with Palos Community Hospital are among the first in Chicago's southwest suburbs to embrace the transradial approach for heart angiograms and clearing blocked arteries. Transradial...
PennDOT, State Police Caution Motorists About Dangers of Driving Under Influence of Legal Drugs
October 25, 2010 11:35 am | by Bio-Medicine.Org | News | CommentsHARRISBURG, Pa., Oct. 25 /PRNewswire-USNewswire/ -- PennDOT and the Pennsylvania State Police are reminding motorists that driving while under the influence of prescription and over-the-counter medication can be just as dangerous as driving under the influence of alcohol and illegal...
GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch'
October 25, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsLILLE, France and CAMBRIDGE, Mass., Oct. 25 /- GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today...
CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
October 25, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsATLANTA, Oct. 25 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during...
Panasonic Makes Investment in Houston-based CardioNexus Corp.
October 25, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsSECAUCUS, N.J., Oct. 25 /- Panasonic Corporation of North America has completed an investment in CardioNexus Corporation, a portfolio company of Houston's Fairway Medical Technologies which works closely with the Texas Medical Center. The move is part of Panasonic's plans to establish...
10 Tips for Breast Cancer Survivors
October 22, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsSEATTLE, Oct. 22 /- Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering weekly research-based tip sheets regarding breast cancer prevention, screening...
